Benilde Fontoba-Poveda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benilde Fontoba-Poveda has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Marc Baget-Bernaldiz
Ophthalmology Service, University Hospital Sant Joan, Institut de Investigacio Sanitaria Pere Virgili (IISPV), Universitat Rovira & Virgili, 43204 Reus, Spain
3 shared publications - Pedro Romero-Aroca
Ophthalmology Service, University Hospital Sant Joan, Institut de Investigacio Sanitaria Pere Virgili (IISPV), Universitat Rovira & Virgili, 43204 Reus, Spain
3 shared publications - Cristian Morente-Lorenzo
Ophthalmology Service, University Hospital Sant Joan, Institut de Investigacio Sanitaria Pere Virgili (IISPV), Universitat Rovira & Virgili, 43204 Reus, Spain
2 shared publications - Eugeni Garcia-Curto
Institut d’Investigació Sanitària Pere Virgili, Tarragona, Catalonia, Spain
2 shared publications - Adriana Hernando-Comerma
Ophthalmology Service, Hospital Universitari Sant Joan, Institut d’Investigació Sanitària Pere Virgili [IISPV], Universitat Rovira i Virgili, 43204 Reus, Spain
1 shared publication - Aida Valls
Universitat Rovira i Virgili
1 shared publication
Latest Publications
- Open Access
- 18 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6935
Two Handheld Retinograph Devices Evaluated by Ophthalmologists and an Artificial Intelligence Algorithm
Background/Objectives: Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help in screening diabetes. Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images for comparison with OCT. Evaluation was carried out in two stages: the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. Results: The retina specialists reported that the smartphone images required mydriasis in all cases, compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and in 7.98% with the smartscope. The detection of any DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1 scores (0.89) than the smartscope, with 0.99. Low results were also obtained using the smartphone to detect mild DR (146 retinographs), compared to using the smartscope (218 retinographs). Conclusions: we consider that the use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although the ease of image acquisition through small pupils with these devices needs to be improved.
- 18 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6935
Open AccessTwo Handheld Retinograph Devices Evaluated by Ophthalmologists and an Artificial Intelligence Algorithm
Background/Objectives: Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help in screening diabetes. Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images for comparison with OCT. Evaluation was carried out in two stages: the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. Results: The retina specialists reported that the smartphone images required mydriasis in all cases, compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and in 7.98% with the smartscope. The detection of any DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1 scores (0.89) than the smartscope, with 0.99. Low results were also obtained using the smartphone to detect mild DR (146 retinographs), compared to using the smartscope (218 retinographs). Conclusions: we consider that the use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although the ease of image acquisition through small pupils with these devices needs to be improved.
- Open Access
- 10 September 2024
- Published by MDPI AG in Preprints.org
Real World Analysis of Two Handheld Retinograph, Evaluation by Ophthalmologist and an Artificial Intelligence Algorithm
(1) Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help diabetes screening. (2) Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images comparing OCT. Evaluation was done in two stages, the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. (3) Results: The retina specialists report that the smartphone images must mydriasis in all cases compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and 7.98% with the smartscope. The detection of any-DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1scores (0.89) than the smartscope, with 0.99. The detection of Mild-DR using the smartphone also obtained low results (146 retinographs) compared to the smartscope (218 retinographs). (4) Conclusions: The use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although these devices need to improve the ease image acquisition through small pupils.
- 10 September 2024
- Published by MDPI AG in Preprints.org
Open AccessReal World Analysis of Two Handheld Retinograph, Evaluation by Ophthalmologist and an Artificial Intelligence Algorithm
(1) Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help diabetes screening. (2) Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images comparing OCT. Evaluation was done in two stages, the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. (3) Results: The retina specialists report that the smartphone images must mydriasis in all cases compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and 7.98% with the smartscope. The detection of any-DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1scores (0.89) than the smartscope, with 0.99. The detection of Mild-DR using the smartphone also obtained low results (146 retinographs) compared to the smartscope (218 retinographs). (4) Conclusions: The use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although these devices need to improve the ease image acquisition through small pupils.
- Open Access
- 9 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1992
Artificial Intelligence-Based Screening System for Diabetic Retinopathy in Primary Care
Background: This study aimed to test an artificial intelligence-based reading system (AIRS) capable of reading retinographies of type 2 diabetic (T2DM) patients and a predictive algorithm (DRPA) that predicts the risk of each patient with T2DM of developing diabetic retinopathy (DR). Methods: We tested the ability of the AIRS to read and classify 15,297 retinal photographs from our database of diabetics and 1200 retinal images taken with Messidor-2 into the different DR categories. We tested the DRPA in a sample of 40,129 T2DM patients. The results obtained by the AIRS and the DRPA were then compared with those provided by four retina specialists regarding sensitivity (S), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), accuracy (ACC), and area under the curve (AUC). Results: The results of testing the AIRS for identifying referral DR (RDR) in our database were ACC = 98.6, S = 96.7, SP = 99.8, PPV = 99.0, NPV = 98.0, and AUC = 0.958, and in Messidor-2 were ACC = 96.78%, S = 94.64%, SP = 99.14%, PPV = 90.54%, NPV = 99.53%, and AUC = 0.918. The results of our DRPA when predicting the presence of any type of DR were ACC = 0.97, S = 0.89, SP = 0.98, PPV = 0.79, NPV = 0.98, and AUC = 0.92. Conclusions: The AIRS performed well when reading and classifying the retinographies of T2DM patients with RDR. The DRPA performed well in predicting the absence of DR based on some clinical variables.
- 9 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1992
Open AccessArtificial Intelligence-Based Screening System for Diabetic Retinopathy in Primary Care
Background: This study aimed to test an artificial intelligence-based reading system (AIRS) capable of reading retinographies of type 2 diabetic (T2DM) patients and a predictive algorithm (DRPA) that predicts the risk of each patient with T2DM of developing diabetic retinopathy (DR). Methods: We tested the ability of the AIRS to read and classify 15,297 retinal photographs from our database of diabetics and 1200 retinal images taken with Messidor-2 into the different DR categories. We tested the DRPA in a sample of 40,129 T2DM patients. The results obtained by the AIRS and the DRPA were then compared with those provided by four retina specialists regarding sensitivity (S), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), accuracy (ACC), and area under the curve (AUC). Results: The results of testing the AIRS for identifying referral DR (RDR) in our database were ACC = 98.6, S = 96.7, SP = 99.8, PPV = 99.0, NPV = 98.0, and AUC = 0.958, and in Messidor-2 were ACC = 96.78%, S = 94.64%, SP = 99.14%, PPV = 90.54%, NPV = 99.53%, and AUC = 0.918. The results of our DRPA when predicting the presence of any type of DR were ACC = 0.97, S = 0.89, SP = 0.98, PPV = 0.79, NPV = 0.98, and AUC = 0.92. Conclusions: The AIRS performed well when reading and classifying the retinographies of T2DM patients with RDR. The DRPA performed well in predicting the absence of DR based on some clinical variables.